Press Releases

Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce the Appointment of Narayan Prabhu as Chief Financial Officer

Nov 04, 2020

Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business Combination

Jul 21, 2020

Reviva Pharmaceuticals Announces Successful Completion of Pre-IND Meeting with FDA on Brilaroxazine for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Jun 03, 2019

Reviva Pharmaceuticals Selected as a Winner of the 2018 Red Herring Top 100 Global Award

Oct 29, 2018

Reviva Pharmaceuticals Chosen as a 2018 Red Herring Top 100 North America Winner

Jun 26, 2018

Reviva Pharmaceuticals Receives FDA Orphan Designation for RP5063 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Apr 09, 2018